Remedica is specialised in the development and supply of pharmaceutical products for out-licensing. It offers attractive out-licensing opportunities to companies throughout the globe in a wide range of therapeutic areas. The offered dossiers comply with all applicable international and European standards. Together with you, Remedica will work towards the most cost effective solution aiming to be a sustainable partner that offers tailored solutions according to your specific needs and requirements.

Active SubstancePharmaceutical FormTherapeutic Category
Abacavir / Lamivudine300mg FC TabletsAntiviral for systemic use
Abacavir / Lamivudine600mg FC TabletsAntiviral for systemic use
Anastrozole1mg FC TabletsEndocrine therapy (hormone antagonist)
Atazanavir100mg CapsulesProtease inhibitor
Atazanavir150mg CapsulesProtease inhibitor
Atazanavir200mg CapsulesProtease inhibitor
Atazanavir300mg CapsulesProtease inhibitor
Capecitabine150mgAnti-neoplastic agent
Capecitabine500mg FC TabletsAnti-neoplastic agent
Cinacalcet30mg FC TabletsCalcium Homeostasis (Anti-parathyroid agent)
Cinacalcet60mg FC TabletsCalcium Homeostasis (Anti-parathyroid agent)
Cinacalcet90mg FC TabletsCalcium Homeostasis (Anti-parathyroid agent)
Clozapine25mg FC TabletsPsycholeptic
Clozapine100mg FC TabletsPsycholeptic
Darunavir75mg FC TabletsAntiviral for systemic use
Darunavir150mg FC TabletsAntiviral for systemic use
Darunavir300mg FC TabletsAntiviral for systemic use
Darunavir400mg FC TabletsAntiviral for systemic use
Darunavir600mg FC TabletsAntiviral for systemic use
Darunavir800mg FC TabletsAntiviral for systemic use
Efavirenz/Emtricitabine/Tenofovir Disoproxil200mg FC TabletsAntiviral for systemic use
Efavirenz/Emtricitabine/Tenofovir Disoproxil245mg FC TabletsAntiviral for systemic use
Efavirenz/Emtricitabine/Tenofovir Disoproxil600mg FC TabletsAntiviral for systemic use
Emtricitabine / Tenofovir Disoproxil200mg FC TabletsAntiviral for systemic use
Emtricitabine / Tenofovir Disoproxil245mg FC TabletsAntiviral for systemic use
Entecavir0.5mg FC TabletsAntiviral for systemic use
Entecavir1mg FC TabletsAntiviral for systemic use
Erlotinib25mg FC TabletsAntineoplastic agent
Erlotinib50mg FC TabletsAntineoplastic agent
Erlotinib100mg FC TabletsAntineoplastic agent
Erlotinib150mg FC TabletsAntineoplastic agent
Exemestane25mg FC TabletsEndocrine therapy (hormone antagonist)
Gefitinib250mg FC TabletsAntineoplastic agent
Imatinib100mg FC TabletsAntineoplastic agent
Imatinib400mg FC TabletsAntineoplastic agent
Ivabradine5mg FC TabletsCardiac therapy
Ivabradine7.5mg FC TabletsCardiac therapy
Phenoxymethylpenicillin800mg FC tabletsAntibacterial for systemic use
Phenoxymethylpenicillin1000mg FC tabletsAntibacterial for systemic use
Rasagiline1mg TabletsAnti-Parkinson drug
Sorafenib200 mg FC TabletsTyrosine Kinase inhibitor, Angiogenesis Inhibitor
Sunitinib12.5mg CapsulesAntineoplastic agent
Sunitinib25mg CapsulesAntineoplastic agent
Sunitinib37.5mg CapsulesAntineoplastic agent
Sunitinib50mg CapsulesAntineoplastic agent
Tenofovir Disoproxil123mg FC TabletsAntiviral for systemic use
Tenofovir Disoproxil163mg FC TabletsAntiviral for systemic use
Tenofovir Disoproxil204mg FC TabletsAntiviral for systemic use
Tenofovir Disoproxil245mg FC TabletsAntiviral for systemic use

*Patent Information: Availability of products is subject to patent restrictions in countries where applicable patents are in effect.